The ecosystem of cardiology guidelines - Patrons of the state of the art in cardiology - Part I;E(TI)cossistema da cardiologia diretriz, mecenas do estado da arte

Arquivos Brasileiros de Cardiologia

Volumn 89, Issue 5, 2007, Pages

  Grinberg, Max ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bioethics; Comment publication type ; Expert testimony; Guidelines

Indexed keywords

BIOETHICS; CARDIOLOGY; CULTURAL FACTOR; HUMAN; MORALITY; NOMENCLATURE; PRACTICE GUIDELINE; REVIEW;

EID: 37348999901     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/s0066-782x2007001700014     Document Type: Review

References (104)

1. Greenhalg T. Narrative-based medicine in an evidence-based world. BMJ. 1999; 318: 323-5.
2. Grinberg M. Clínica soberana, exame poderoso, bioética suprema corte. Diagn Tratamento. 2005:10:104-6.
3. Arendt H. Entre o passado e o futuro. São Paulo: Editora Perspectiva; 1968.
4. Grinberg M. Triângulos da beira do leito. Diag Tratamento. 2006; 11: 244-6.
5. Norman G. The paradox of evidence-based-medicine. J Eval Clin Pract. 2003; 9: 129-32
6. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006; 114: e84-231.
7. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol. 2006; 48: e247-346.
8. Projeto Diretrizes. Associação Médica Brasileira: Conselho Federal de Medicina. São Paulo, 2004.
9. Grinberg M. Epônimos em cardiologia. São Paulo: Ed. Roca; 1999. p. 29.
10. Harken DE, Soroff HS, Taylor WJ, Lefemine AA, Gupta SK, Lunzer S. Partial and complete prostheses in aortic insufficiency. J Thorac Cardiovasc Surg. 1960; 40: 744-62.
11. Loewenstein G. Hot-cold empathy gaps and medical decision making. Health Psychol. 2005; 24: S49-56.
12. Borry P, Schotsmans P, Dierickx K. Author, contributor or just a signer? A quantitative analysis of authorship trends in the field of bioethics. Bioethics. 2006; 20: 213-20.
13. Rosenhek R, Rader F, Loho N, Gabriel H, Heger H, Klaar U, et al. Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation. 2004; 110: 1291-5.
14. Rosenhek R. Statins for aortic stenosis. N Engl J Med. 352: 2441-3.
15. Bonow RO, Carabello B, de León AC Jr, Edmunds LH Jr, Fedderly BJ, Freed MD et al. ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on management of patients with valvular heart disease). J Am Coll Cardiol. 1998; 32: 1486-588.
16. Kereiakes DJ, Antman EM. Clinical guidelines and practice: in search of the truth. J Am Coll Cardiol. 2006; 48: 1129-35.
17. Manchikanti L, Kloth D, Singh V. The role of guidelines in interventional pain medicine: let us separate apples and oranges. Pain Physician. 2001; 4: 14-23.
18. Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ. 1999; 318: 527-30.
19. Rodondi N, Bauer DC. Assessing the risk/benefit profile before recommending aspirin for the primary prevention of cardiovascular events. Am J Med. 2004; 117: 528-30.
20. Tan KBH. Clinical practice guidelines:a critical review. Int J Health Care Qual Assur Inc Leadersh Health Serv. 2006; 19: 195-220.
21. Rendenbach U, Grosse K. Guideline skatingfor the family doctor. MMW Fortschr Med. 2006; 148: 30-3.
22. Smith GC, Pell JP. Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. BMJ. 2003; 327:1459-61.
23. Concato J, Dhah N, Horwitz RI. Randomized controlled trials, observational studies, and hieraquy of research designs. N Engl J Med. 2000; 342: 1887-92.
24. Gupta M. A critical appraisal of evidence-based-medicine: some ethical considerations. J Eval Clin Pract. 2003; 9: 111-21.
25. Van Tassel K. Hospital peer review standards and due process: moving from tort doctrine toward contract principles based on clinical practice guidelines. Seton Hall Law Rev. 2006; 36: 1179-256.
26. Calderon C, Rotaeche R, Etxebarria A, Marzo M, Rico R, Barandiaran M. Gaining insight into the Clinical Practice Guideline development processes: qualitative study in a workshop to implement the GRADE proposal in Spain. BMC Health Serv Res. 2006; 6138.
27. Cronje R, Fullan A. Evidence-based medicine: toward a new definition of "rational" medicine. Health. 2003; 7: 353-69.
28. Thompson DF. Understanding financial conflicts of interest. N Engl J Med. 1993; 329: 573-6.
29. Jenieck M. Epidemiology, evidenced-based medicine, and evidence-based public health. J Epidemiol. 1997; 7: 187-97.
30. Sonnenberg FA, Hagerty CG. Computer-interpretable clinical practice guidelines - Where are we and where are we going? Methods Inf Med. 2006; 45 (Suppl 1): 145-58.
31. Lockey D, Crewdson K, Davies G. Traumatic cardiac arrest: who are the survivors? Ann Emerg Med. 2006; 48: 240-4.
32. Fretheim A, Oxman AD, Håvelsrud K, Treweek S, Kristoffersen DT, Bjørndal A. Rational prescribing in primary care (RaPP): a cluster randomized trial of a tailored intervention Plos Med. 2006; 3: e134.
33. Pocock SJ, Elbourne DR. Randomized trials or observational tribulations? N Engl J Med. 2000; 342: 1907-9.
34. Steinberg D. Lipoproteins and atherosclerosis: some unanswered questions. Am Heart J. 1987; 113: 626-32.
35. Hester DM. Is pragmatism well-suited to bioethics? J Med Philos. 2003; 28: 545-61.
36. Rose G. Strategy of prevention: lessons from cardiovascular disease. BMJ. 1981; 282: 1847-51.
37. Antunes MJ. Aortic stenosis of the elderly: rethinking strategies. Eur J Cardiothorac Surg. 2006; 30: 713-4.
38. Ramires JAF, Lemos PC. A didática humanista do Professor Luiz Venere Décourt. São Paulo: Editora Atheneu, 2005.
39. Borry P, Schotsmans P, Dierickx K. Evidence-based medicine and its role in ethical decision-making. J Eval Clin Pract. 2006; 12: 306-11.
40. Pennachio DL. Clinical guidelines sword or shield? Med Econ. 2004; 81: 22-4.
41. Feder G, Eccles M, Grol R, Griffiths S, Grimshaw J. Using guidelines. BMJ. 1999; 318: 728-30.
42. Couto J. An objetivist's view on the ethics of evidence-based medicine. J Eval Clin Pract. 2003; 9: 137-9.
43. McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, Decristofaro A, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003; 348: 2635-45.
44. Lenfant C. Shattuck lecture: clinical research to clinical practice - lost in translation? N Engl J Med. 2003; 349: 868-74.
45. van Loo L, Leonard N. Fifteen hundred guidelines and growing: the UK database of clinical guidelines. Health Info Libr J. 2006; 23 (2): 95-101.
46. Goodman SN. Toward evidence-based medical statistics. 1: the P value fallacy. Ann Intern Med. 1999; 130: 995-1004.
47. Fye WB. The power of clinical trials and guidelines, and the challenge of conflicts of interest. J Am Coll Cardiol. 2003; 41: 1237-42.
48. Garcia-Berthou E, Alcaraz C. Incongruence between test statistics and P values in medical papers. BMC Med Res Methodol. 2004; 4: 13.
49. Shahar E. On morality and logic in medical practice. J Eval Clin Pract. 2003; 9: 133-5.
50. Tonelli MR. Integrating evidence into clinical practice: an alternative to evidence-based approaches. J Eval Clin Pract. 2006; 12: 248-56.
51. Rosoff PM. Can underpowered clinical trials be justified? IRB. 2004; 26: 16-9.
52. DeMaria AN. Populism in guideline writing. J Am Coll Cardiol. 2006; 48: 1109-10.
53. Grol R, Buchan H. Clinical guidelines: what can we do to increase their use? Med J Aust. 2006; 185: 301-2.
54. Syed MA, Carlson K, Murphy M, Ingkanisorn WP, Rhoads KL, Arai AE. Long-term safety of cardiac magnetic resonance imaging performed in the first few days after bare-metal stent implantation. J Magn Reson Imaging. 2006; 24 (5): 1056-61.
55. Papper M. The "practice" of medicine. Ann Intern Med. 2006; 145: 308-9.
56. Grinberg M. Acaso da beira do leito, causo da bioética. Arq Bras Cardiol. 2006; 87: e257-e61.
57. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003; 13: 1231-43.
58. Geanellos R, Wilson C. Building bridges: knowledge production, publication and use. Commentary on Tonelli (2006), Integrating evidence into clinical practice: an alternative to evidence-based approaches. J Eval Clin Pract. 2006; 12: 248-56.
59. Friedman LS, Richter ED. Relationship between conflicts of interest and research results. J Gen Intern Med. 2004; 19: 51-6.
60. DeAngelis CD, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. JAMA. 2004; 292: 1363-4.
61. DeAngelis CD, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, et al. Is this clinical trial fully registered? JAMA. 2005; 293: 2927-9.
62. Gilbody SM, Song F. Publication bias and the integrity of psychiatry research. Psychol Med. 200; 30: 253-8.
63. Beauchamp TL. Methods and principles in biomedical ethics. J Med Ethics. 2003: 29: 269-74.
64. Ben-Yehuda O. Physician judgment in cardiology: the art of medicine lives on. J Am Coll Cardiol. 2006; 48: 954-5.
65. Mc Nutt RA. Shared medical decision making: problems, process, progress. JAMA. 2004; 292: 2516-8.
66. Coulter A. Shared decision-making: the debate continues. Health Expect. 2005; 8: 95-6.
67. Goodney PP, O'Connor GT, Wennberg DE, Birkmeyer JD. Do hospitals with low mortality rates in coronary artery bypass also perform well in valve replacement? Ann Thorac Surg. 2003; 76: 1131-6.
68. Tarasoutchi F, Grinberg M, Spina GS, Sampaio RO, Cardoso LF, Rossi EG, et al. Ten-year clinical laboratory follow-up after application of a symptom-based therapeutic strategy to patients with severe chronic aortic regurgitation of predominant rheumatic etiology. J Am Coll Cardiol. 2003; 41: 1316-24.
69. Bonow RO, Lakatos E, Maron BJ, Epstein SE. Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function. Circulation. 1991; 84: 1625-35.
70. Psaty BM, Weiss NS, Furberg CD. Recent trials in hypertension: compelling science or commercial speech? JAMA. 2006; 295: 1704-6.
71. Psaty BM, Burke SP. Protecting the health of the public - Institute of Medicine recommendations on drug safety. N Engl J Med. 2006; 355 (17): 1753-5.
72. Williams SC, Koss RG, Morton DJ, Loeb JM. Performance of top-ranked heart care hospitals on evidence-based process measures. Circulation. 2006;114: 558-64
73. Freeman AC, Sweeney K. Why general practitioners do not implement evidence qualitative study. BMJ. 2001; 323: 1100-2.
74. Moumjid N, Gafni A, Bremond A, Carrere MO. Seeking a second opinion: do patients need a second opinion when practice guidelines exist? Health Policy. 2006; 80 (1): 43-50.
75. Wong DM, Blumberg DA, Lowe LG. Guidelines for the use of antibiotics in acute upper respiratory tract infections. Am Fam Physician. 2006; 74: 956-66.
76. Grunkemeier GL, Jin R, Starr A. Prosthetic heart valves: objective performance criteria versus randomized clinical trials. Ann Thorac Surg. 2006; 82: 776-80.
77. Grinberg M. Proíbo, logo assisto. Arq Bras Cardiol. 2005: 85: 283-6.
78. Gowdy AD. What guidelines? Never saw them! Plos Med. 2006; 3: e413.
79. Barnhart JM, Cohen O, Wright N, Wylie-Rosett J. Can non-medical factors contribute to disparities in coronary heart disease treatments. J Health Care Poor Underserved. 2006;17: 559-74.
80. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000; 30: 633-8.
81. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005; 294: 716-24.
82. Welch HG, Albertsen PC, Nease RF, Bubolz TA, Wasson JH. Estimating treatment benefits for the elderly: the effect of competing risks. Ann Intern Med. 1996; 124: 577-84.
83. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003; 348: 383-93.
84. Tsur A, Harman-Bohem I, Buchs AE, Raz I, Wainstein J. The guidelines for the diagnosis, prevention and treatment of type 2 diabetes mellitus-2005. Harefuah. 2006; 145: 583-6.
85. Grol R, Dalhuijsen J, Thomas S, Veld C, Rutten G, Mokkink H. Attributes of clinical guidelines that influence use of guidelines in general practice: observational study. BMJ. 1998; 317: 858-61.
86. Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Chadwick D, Guerreiro C, et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2006; 47: 1094-120.
87. Maue SK, Segal R, Kimberlin CL, Lipowski EE. Predicting physician guideline compliance: an assessment of motivators and perceived barriers. Am J Manag Care. 2004; 10: 383-91.
88. Pereira AC, Lopes NH, Soares PR, Krieger JE, Oliveira SA, Cesar LA, et al. Clinical judgment and treatment options in stable multivessel coronary artery disease: results from the one-year follow-up of the MASS II (Medicine, Angioplasty or Surgery Study II). J Am Coll Cardiol. 2006; 48: 948-53.
89. Chagas C. Nova tripanozomíase humana: estudos sobre a morfologia e o ciclo evolutivo do Schizotrypanum cruzi, agente etiológico de nova entidade mórbida no homem. Mem Inst Oswaldo Cruz. 1909; 1: 159-218.
90. Fontanarosa PB, Flanagin A, DeAngelis CD. Reporting conflicts of interest, financial aspects of research, and role of sponsors in funded studies. JAMA. 2005; 294: 110-1.
91. Tanne JH. Doctors who write guidelines often have ties to the drug industries. Nature. 2005: 437: 1070-1.
92. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA. 2003; 289: 454-65.
93. Psaty B, Weiss NS, Furberg C. Recent trials in hypertension: compelling science or commercial speech? JAMA. 2006; 295: 1704-6.
94. V Brazilian guidelines for arterial hypertension 2006. Int J Atheroscler. 2006; 1: 71-123.
95. Genuis SJ, Genuis SK. Resisting cookbook medicine. BMJ. 2004; 329: 179.
96. Azpitarte J, Alonso AM, Gonzales FGG, Santos JMG, Pare C, Tello A. Guías de práctica clínica de la Sociedad Española de Cardiología en valvulopatías. Rev Esp Cardiol. 2000; 53: 1384-96.
97. II Diretriz Brasileira de Cardiopatia Grave. Arq Bras Cardiol. 2006; 87: 223-32.
98. Mehta NB. The doctor's challenge: how can we follow guidelines better? Cleve Clinic J Med. 2004; 71: 81-5.
99. Graham IM, Stewart M, Hertog MG. Factors impeding the implementation of cardiovascular prevention guidelines: findings from a survey conducted by the European Society of Cardiology. Eur J Prev Rehabil. 2006; 13: 839-45.
100. Otten K, Geraedts M, Kugler C. Critical appraisal of stroke guidelines. Z Arztl Fortbild Qualitatssich. 2006; 100: 275-81.
101. Morimoto T, Fukui T, Lee TH, Matsui K. Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan. Am J Med. 2004; 117: 459-68.
102. Liu J, Hong Y, D'Agostino RB, Wu Z, Wang W, Sun J, et al. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA. 2004; 291: 2591-9.
103. Sackett. The sins of expertness and a proposal for redemption. BMJ. 2000; 320: 1283.
104. Bonati M. The cry of an intellectual. [on line]. [acesso em 2007 jan 20]. [Disponível em : http://www.bmj.com/cgi/eletters/320/7244/1283#7857].